Since the World Health Organization has declared the Covid-19 a ‘pandemic’ on 11 March 2020, many affected countries have taken up protectionist measures to control the further spread of the disease. Almost one-third of the global population is under some of restrictions or ‘lockdown’ to ensure social distancing.
The report published by Global Market Estimates provides a detailed analysis on the Economic Impact and Market Forecasts to 2026 for 30 countries which have been majorly affected by COVID pandemic. This report uses econometric modelling to forecast the effect of COVID-19 pandemic on these 30 countries over the next 6 years.
Request for a sample copy of the report @: Economic Impact and Market Forecasts to 2026 for Gross Domestic Product, Tourism/Travel, and Medical Industry - By Country
The report provides an in-depth analysis and forecasts for each of the countries. The parameters or the segments considered includes: Gross Domestic Product, Tourism/Travel, and Medical Industry. The report also covers more than 100 key manufactures who will play a crucial role during the forecast period.
Some of the tables covered in the report for Gross Domestic Product, By Country [2020-2026] are stated below. Similarly, the report covers tables related to Tourism/Travel, and Medical Industry at a country level:
- U.S, Gross Domestic Product, 2020-2026 (USD Billion)
- Spain, Gross Domestic Product, 2020-2026 (USD Billion)
- Italy, Gross Domestic Product, 2020-2026 (USD Billion)
- Germany, Gross Domestic Product, 2020-2026 (USD Billion)
- France, Gross Domestic Product, 2020-2026 (USD Billion)
- China, Gross Domestic Product, 2020-2026 (USD Billion)
- Iran, Gross Domestic Product, 2020-2026 (USD Billion)
- United Kingdom, Gross Domestic Product, 2020-2026 (USD Billion)
- Tukey, Gross Domestic Product, 2020-2026 (USD Billion)
- Belgium, Gross Domestic Product, 2020-2026 (USD Billion)
- The Netherlands, Gross Domestic Product, 2020-2026 (USD Billion)
- Canada, Gross Domestic Product, 2020-2026 (USD Billion)
- Switzerland, Gross Domestic Product, 2020-2026 (USD Billion)
- Brazil, Gross Domestic Product, 2020-2026 (USD Billion)
- Portugal, Gross Domestic Product, 2020-2026 (USD Billion)
- South Korea, Gross Domestic Product, 2020-2026 (USD Billion)
- Russia, Gross Domestic Product, 2020-2026 (USD Billion)
- Australia, Gross Domestic Product, 2020-2026 (USD Billion)
- Sweden, Gross Domestic Product, 2020-2026 (USD Billion)
- India, Gross Domestic Product, 2020-2026 (USD Billion)
- Japan, Gross Domestic Product, 2020-2026 (USD Billion)
- Saudi Arabia, Gross Domestic Product, 2020-2026 (USD Billion)
- UAE, Gross Domestic Product, 2020-2026 (USD Billion)
- Singapore, Gross Domestic Product, 2020-2026 (USD Billion)
- New Zealand, Gross Domestic Product, 2020-2026 (USD Billion)
- South Africa, Gross Domestic Product, 2020-2026 (USD Billion)
- Denmark, Gross Domestic Product, 2020-2026 (USD Billion)
- Malaysia, Gross Domestic Product, 2020-2026 (USD Billion)
- Indonesia, Gross Domestic Product, 2020-2026 (USD Billion)
- Mexico, Gross Domestic Product, 2020-2026 (USD Billion)
The Key Players profiled in the report include:
- Therapeutics
- Applied DNA Sciences, Inc
- Codagenix
- GeoVax Labs, Inc
- Takis Biotech
- Evvivax
- Zydus Cadila
- MIGAL Galilee Research Institute
- Generex Biotechnology Corporation
- Moderna Therapeutics
- Novavax
- Bravovax
- Ascletis Pharma
- Janssen Pharmaceuticals
- Altimmune
- Greffex Inc
- CanSino Biologics, Inc
- ExpreS2ion Biotechnologies ApS
- Clover Biopharmaceuticals
- Vaxil Bio Ltd
- iBio Pharma Inc
- Tonix Pharmaceuticals
- Curevac
- ImmunoPrecise
- X4 Pharmaceuticals
- Inovio Pharmaceuticals
- Innovation Pharmaceuticals
- CytoDyn
- BIOXYTRAN
- BioCryst Pharmaceuticals
- Vir Biotechnology
- NanoViricides
- TAKISAWA Technology Co., Ltd
- Westway Health
- NabrivaTherapeutics
- NemesisBioscience
- Armata Pharmaceuticals, Inc
- Lumavita
- Priaxon
- Union Therapeutics
- Enanta Pharmaceuticals, Inc
- Demuris
- Prommune
- Vaxart
- Alexion Pharmaceuticals
- SelectXPharmaceuticals, Inc
- TaiGen Biotechnology Co., Ltd
- Abbvie
- KYORIN Pharmaceutical Co., Ltd
- Forge Therapeutics
- Alopexx Vaccine LLC
- Integrated Biotherapeutics
- Hennepin Life Sciences
- Contrafect Corporation
- Basilea Pharmaceutica Ltd
- AiCuris
- Redx Pharma Plc/ Redx Anti Infectives Ltd
- Centauri Therapeutics Ltd
- Combioxin SA
- Mutabilis SAS
- Vaxdyn
- Vibiosphen
- Bioaster
- Vivexia
- KBP Biosciences
- Merck
- Symphogen
- Johnson & Johnson (Janssen)
- Pfizer
- Allergan
- GlaxoSmithKline
- Novartis
- Gilead Sciences
- AstraZeneca
- Sanofi
- Shionogi Inc
- Cipla
- DSM Sinochem Pharmaceuticals
- Wockhardt Ltd
- VenatoRx Pharmaceuticals
- 5.2 Key Players-Diagnostics
- Abbott Diagnostics
- Accelerate Diagnostics
- Ador Diagnostics
- Akkoni Biosystems
- Alveo Technologies
- Applied BioCode
- Aus Diagnostics
- BD Diagnostics
- Biocartis
- BioFire Diagnostics
- bioMérieux
- Bio-Rad Laboratories
- Bosch Healthcare Solutions GmbH
- Cepheid
- Co-Diagnostics
- Cue Health
- Curetis
- Diagenode Diagnostics
- Diascopic
- Diasorin
- Expedeon
- Fusion Genomics
- GenePOC Diagnostics
- GenMark Dx
- Hologic
- Immunexpress
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Lexigene
- Luminex
- Mbio Diagnostics
- Meridian Bioscience
- Mesa Biotech
- Mobidiag
- Nanomix
- Oxford Nanopore
- Panagene
- Primerdesign
- Prominex
- Qiagen (Statdx)
- Quantumdx
- Quidel
- Roche Molecular Diagnostics
- Saw Diagnostics
- Seegene
- Sensovation
- Siemens Healthineers (Fast Track Diagnostics)
- SkylineDx
- Sona Nanotech
- T2 Biosystems
- Thermo Fisher
- Veradus Labs
- Veramarx
- Other Companies
Please note: This is not an exhaustive list of companies.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Economic Impact and Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
